Rothschild Investment LLC Spring Works Therapeutics, Inc. Transaction History

Rothschild Investment LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$34.43 - $46.99 $688 - $939	20 Added 18.18%	130 $6.11 Million
Q1 2025 Apr 08, 2025	BUY	$32.5 - $59.93 $487 - $898	15 Added 15.79%	110 $4.85 Million
Q4 2024 Feb 04, 2025	BUY	$28.61 - $42.55 $1,001 - $1,489	35 Added 58.33%	95 $3.43 Million
Q3 2024 Oct 18, 2024	BUY	$32.04 - $42.76 $1,602 - $2,138	50 Added 500.0%	60 $1.92 Million
Q2 2024 Jul 30, 2024	BUY	$36.06 - $47.62 $360 - $476	10 New	10 $377,000

Q1 2024 Jul 31, 2024	SELL	$36.5 - $52.5 $182 - $262	-5 Reduced 50.0%	5 $246,000

7.36M

23K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.93B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

Stay updated on Rothschild Investment LLC with notifications on news.